Cardiac arrhythmias презентация

Содержание

Слайд 2

Слайд 3

Слайд 4

Слайд 5

Слайд 6

Слайд 7

Слайд 8

Слайд 9

Normal Sinus rhythm

Normal Sinus rhythm

Слайд 10

Classification Tachyarrhythmia: - Supraventricular - Ventricular Bradiarrhythmia

Classification

Tachyarrhythmia:
- Supraventricular
- Ventricular
Bradiarrhythmia

Слайд 11

APB or PAC

APB or PAC

Слайд 12

Atrial Fibrillation The most common arrhythmia in clinical practice Frequency increases with age

Atrial Fibrillation

The most common arrhythmia in clinical practice
Frequency increases with age

Слайд 13

Irregularly irregular rhythm No P waves F waves

Irregularly irregular rhythm
No P waves
F waves

Слайд 14

Mechanism

Mechanism

Слайд 15

Most common causes Valvular heart disease: (MS,MR) LV hypertrophy (HTN,

Most common causes

Valvular heart disease: (MS,MR)
LV hypertrophy (HTN, other cause)
Cardiomyopathy
Thyrotoxicosis
Alcohol (“holiday

heart”)
Atrial septal defect
Lone AF (structurally normal heart)
Слайд 16

Rapid AF

Rapid AF

Слайд 17

Consequences of Atrial Fibrillation Hemodynamic loss of synchronous atrial mechanical

Consequences of Atrial Fibrillation

Hemodynamic
loss of synchronous atrial mechanical activity
irregularity of ventricular

response
inappropriately rapid heart rate
Myocardial – persistently rapid rate can lead to:
atrial cardiomyopathy
dilated ventricular cardiomyopathy
Thromboembolism
ischemic stroke and systemic arterial occlusion attributed to LA and LAA thrombus
Слайд 18

Classification

Classification

Слайд 19

Treatment options 1. Rhythm control – restoration and maintenance of

Treatment options

1. Rhythm control – restoration and maintenance of sinus rhythm
2.

Rate control

Prevention of Thromboembolysm !

Слайд 20

Williams Classification of Antyarrhythmic Drugs Class I- blocking the fast

Williams Classification of Antyarrhythmic Drugs

Class I- blocking the fast Na channels:

IA – Reduce V max and prolong action potential
Quinidine
Procainamide
Disopiramide
Слайд 21

IB : Do not reduce V max and shorten action

IB : Do not reduce V max and shorten action

potential duration
Lidocaine
Phenytoin
Mexiletine
IC: Reduce V max
Flecainide
Propafenon
Слайд 22

Class II – beta blockers Class III – K channel

Class II – beta blockers
Class III – K channel blockers
-

Amiodaron
- Sotalol
- Bretylium
Class IV – Ca channel blockers
Слайд 23

Cardioversion Pharmacological Propafenon Amiodaron Flecainide

Cardioversion

Pharmacological
Propafenon
Amiodaron
Flecainide

Слайд 24

Cardioversion Electric In acute setting (hemodynamically unstable pt) In Chronic Setting Elective cardioversion

Cardioversion


Electric
In acute setting (hemodynamically unstable pt)
In Chronic Setting
Elective cardioversion

Слайд 25

Predictors of successful cardioverson Short AF duration Young age Normal atrial size No organic heart pathology

Predictors of successful cardioverson

Short AF duration
Young age
Normal atrial size
No organic heart

pathology
Слайд 26

Maintenance of sinus rhythm Propafenon Amiodaron Dronedaron Sotalol Flecainide

Maintenance of sinus rhythm

Propafenon
Amiodaron
Dronedaron
Sotalol
Flecainide

Слайд 27

Слайд 28

Слайд 29

Rate Control Acute setting – IV - Esmolol - Metoprolol

Rate Control

Acute setting – IV
- Esmolol
- Metoprolol
- Verapamil

- Dilthiazem
- Digoxin (HF)
Chronic setting – PO (the same drugs)
Слайд 30

Слайд 31

– Severe symptoms due to AF – Patients with CHF

– Severe symptoms due to AF
– Patients with CHF
– Younger patients

Patients with lone AF
– First episode of AF

Attempt Rhythm Control First

Слайд 32

Rate Control as First-Line Choice Consider rate control as first-line

Rate Control as First-Line Choice
Consider rate control as first-line therapy if:

Patient is relatively asymptomatic
– Older age group
– Absence of CHF
– Restoration of sinus rhythm is unlikely
- AF present >12 months
- LA dimension >6 cm
– Proarrhythmic risk is high
Слайд 33

Left Atrial Appendage

Left Atrial Appendage

Слайд 34

Anticoagulation

Anticoagulation

Слайд 35

CHADS2 score

CHADS2 score

Слайд 36

Слайд 37

Novel Oral Anticoagulants Dabigatran (Pradaxa)- direct oral thrombin inhibitor Rivaroxaban

Novel Oral Anticoagulants

Dabigatran (Pradaxa)- direct oral thrombin inhibitor
Rivaroxaban (Xarelto)– direct oral

factor Xa inhibitor
Apixaban (Eliquis) - direct oral factor Xa inhibitor
Слайд 38

Invasive AF treatment

Invasive AF treatment

Слайд 39

RF ablation

RF ablation

Слайд 40

Invasive AF management Rate control “Ablate and pace” – A-v nodal ablation & Permanent pacemaker

Invasive AF management

Rate control
“Ablate and pace” – A-v nodal

ablation & Permanent pacemaker
Слайд 41

Pulmonary Venous Isolation For recurrent paroxysmal AF

Pulmonary Venous Isolation

For recurrent paroxysmal AF

Слайд 42

Cox-Maze Procedure Left Atrial Isolation (1980) Corridor Procedure (1985) Maze

Cox-Maze Procedure

Left Atrial Isolation (1980)

Corridor Procedure (1985)

Maze Procedure (1987)
Pathway from

the SA to AV Node
Disrupt Macro-reentrant Circuits
Allow Activation of All Atrial Tissue
Слайд 43

Maze

Maze

Слайд 44

LA appendage closure

LA appendage closure

Слайд 45

Atrial flutter

Atrial flutter

Слайд 46

Слайд 47

Слайд 48

Management Electric Cardioversion Slowing Ventricular rate - Beta Blockers -

Management

Electric Cardioversion
Slowing Ventricular rate
- Beta Blockers
- Ca Channel blocker

- Digoxin
Propafenon or Flecainaide
Слайд 49

Prevention Isthmus ablation

Prevention

Isthmus ablation

Слайд 50

Preexitation – WPW syndrome (accessory pathway(

Preexitation – WPW syndrome (accessory pathway(

Слайд 51

AVRT Short PR ( Wide QRS with delta wave ST-T Changes

AVRT

Short PR (<120 msec)
Wide QRS with delta wave
ST-T Changes

Слайд 52

Слайд 53

AVRT

AVRT

Слайд 54

AVRT

AVRT

Слайд 55

Treatment Acute treatment: Wide complex – Procainamide DC Shock Narrow

Treatment

Acute treatment:
Wide complex – Procainamide
DC Shock
Narrow complex –

Verapamil,
Beta Blockers
Preventive treatment : accessory pathway ablation
Слайд 56

AF with WPW – high risk of VF

AF with WPW – high risk of VF

Слайд 57

Double A-V nodal physiology

Double A-V nodal physiology

Слайд 58

Слайд 59

AVNRT

AVNRT

Слайд 60

Management of narrow complex SVT If unstable – DC shock

Management of narrow complex SVT

If unstable – DC shock
If Stable :

1. Vagal maneuvers
2. Adenosin
3. Verapamil
Слайд 61

Preventive treatment Drugs EPS

Preventive treatment

Drugs
EPS

Слайд 62

Ventricular Arrhythmias

Ventricular Arrhythmias

Слайд 63

Ventricular premature beats Ventricular premature complexes premature occurrence of a

Ventricular premature beats Ventricular premature complexes

premature occurrence of a QRS complex

that is abnormal in shape and has a duration usually exceeding the dominant QRS complex, generally longer than 120 milliseconds.
The T wave is usually large and opposite in direction to the major deflection of the QRS.
The QRS complex is not preceded by a premature P wave
Слайд 64

Compensatory pause

Compensatory pause

Слайд 65

Bigeminy

Bigeminy

Слайд 66

Trigeminy

Trigeminy

Слайд 67

VPB’s

VPB’s

Слайд 68

Unifocal & Multifocal

Unifocal & Multifocal

Слайд 69

Couplet & Triplet

Couplet & Triplet

Слайд 70

Causes LV false tendons, infection in ischemic or inflamed myocardium,

Causes

LV false tendons,
infection
in ischemic or inflamed myocardium,
hypoxia,
Anesthesiaor

surgery.
Medications
electrolyte imbalance,
tension states,
myocardial stretch,
excessive use of tobacco, caffeine, or alcohol.
Слайд 71

Complex Ventricular Arrhythmia Nonsustained ventricular tachycardia (VT) ♥ Monomorphic ♥

Complex Ventricular Arrhythmia

Nonsustained ventricular tachycardia (VT)
♥ Monomorphic
♥ Polymorphic
Sustained VT
♥ Monomorphic
♥ Polymorphic
Torsades

de pointes
Ventricular fibrillation
Слайд 72

Definition: Ventricular tachycardia consist of at least three consecutive QRS

Definition:
Ventricular tachycardia consist of at least three consecutive QRS complexes originating

from the ventricles and recurring at a rapid rate (> 100 bpm).
Sustained ventricular tachycardia is arbitrarily defined as lasting > 30 seconds.
The rhythm is generally regular or slightly irregular.

VT

Слайд 73

VT -monomorphic

VT -monomorphic

Слайд 74

Sustained Polymorphic VT

Sustained Polymorphic VT

Слайд 75

VF

VF

Слайд 76

VF with Defibrillation (12-lead ECG)

VF with Defibrillation (12-lead ECG)

Слайд 77

Causes Chronic coronary heart disease Heart failure Congenital heart disease

Causes

Chronic coronary heart disease
Heart failure
Congenital heart disease
Neurological disorders
Structurally normal hearts
Sudden infant

death syndrome
Cardiomyopathies
♥ Dilated cardiomyopathy
♥ Hypertrophic cardiomyopathy
♥ Arrhythmogenic right ventricular (RV)
cardiomyopathy
Слайд 78

Ventricular fibrillation - 62.4% Bradyarrhythmias (including advanced AV block and

Ventricular fibrillation - 62.4%
Bradyarrhythmias (including advanced AV block and asystole) -

16.5%
Torsades de pointes - 12.7%
Primary VT - 8.3%

Mechanisms of Sudden Cardiac Death

Bayes de Luna et al. Am Heart J 1989;117:151–9.

Слайд 79

VA management Acute Chronic (secondary prevention)

VA management

Acute
Chronic (secondary prevention)

Слайд 80

Sustained VT Hemodynamically stable: - Amiodaron - Lidocain - Procainamide

Sustained VT

Hemodynamically stable:
- Amiodaron
- Lidocain
- Procainamide
If pfarmacotherapy ineffective

– DC shock (synchronized)
Ventricular pacing
Hemodinamically unstable – Immediate DC shock
Слайд 81

Polymorphic VT Polymorphic VT with long QT – Torsades de

Polymorphic VT

Polymorphic VT with long QT – Torsades de pointes
Treatment

– Mg , Pacing
Polymorphic VT w/o long QT
Antyarrhytmic drugs
Слайд 82

Слайд 83

Chronic Management (secondary prevention) Evaluation - Rest ECG - Exersise

Chronic Management (secondary prevention) Evaluation
- Rest ECG
- Exersise test
-

Ambulatory ECG
- Imaging (LV function, CMP, Valves etc…
- EPS
Слайд 84

Treatment of the underlying disease Revascularisation Valve surgery CHD repair

Treatment of the underlying disease

Revascularisation
Valve surgery
CHD repair

Слайд 85

♥ Electrolytes: Mg & K ♥ ACE inhibitors, ♥ Antithrombotic

♥ Electrolytes: Mg & K
♥ ACE inhibitors,
♥ Antithrombotic and antiplatelet

agents
♥ Statins

Non-antiarrhythmic Drugs

Слайд 86

Antiarrhytmic drugs Antiarrhythmic drugs (except for BB) should not be

Antiarrhytmic drugs

Antiarrhythmic drugs (except for BB) should not be used as

primary preventive therapy of VA and the prevention of SCD
Слайд 87

Invasive treatment AICD EPS with ablation Surgical ablation

Invasive treatment

AICD
EPS with ablation
Surgical ablation

Слайд 88

AICD for primary prevention of SCD 1.Post MI - LVEF

AICD for primary prevention of SCD

1.Post MI
- LVEF < 30%

- LVEF 30-35%, NYHA II-III
-LVEF 30-40%, NSVT, positive EP
2. Non ischemic CMP
- LVEF <30%
Слайд 89

Long QT syndrome Congenital (family) Acquired: Electrolyte anomalies – K,

Long QT syndrome

Congenital (family)
Acquired:
Electrolyte anomalies – K, Mg
Drug induced
-Antiarrhytmics

- Tricyclic antydepressants
- Antihistamines
CNS lesions
Слайд 90

Слайд 91

Long QT syndrome treatment Acute 1.Remove the precipitating factor 2.

Long QT syndrome treatment

Acute
1.Remove the precipitating factor
2. Mg IV
3. Pacing
4.

Isoproterenol
5. IB antiarrhythmic
Слайд 92

Long QT syndrome treatment Chronic – for congenital long QT 1.Beta blockers 2. AICD

Long QT syndrome treatment

Chronic – for congenital long QT
1.Beta

blockers
2. AICD
Слайд 93

Слайд 94

Brugada syndrome

Brugada syndrome

Слайд 95

Слайд 96

Слайд 97

CLBBB

CLBBB

Слайд 98

CRBBB

CRBBB

Слайд 99

Слайд 100

“Wide Complex Tachycardia” VT SVT with Preexistent BBB Rate dependent BBB Preexitation

“Wide Complex Tachycardia”

VT

SVT with
Preexistent BBB
Rate dependent BBB
Preexitation

Слайд 101

Слайд 102

Wide QRS Irregular Tachycardia: Atrial Fibrillation with antidromic conduction in

Wide QRS Irregular Tachycardia: Atrial Fibrillation with antidromic conduction in patient with

accessory pathway – Not VT
Слайд 103

AV Dissociation QRS > 0.14 QRS Axis between – 90

AV Dissociation
QRS > 0.14
QRS Axis between – 90 & - 180

degrees
Positive QRS deflection in all precordial leads
LBBB morphology with rightward QRS axis
Capture beats, fusion beats
QRS morphology identical to PVC’s during sinus rhythm

Futures favoring VT

Слайд 104

A three-lead rhythm strip from a 62-year-old man who presented

A three-lead rhythm strip from a 62-year-old man who presented with

acute shortness of breath 2 months after an inferior-posterior MI. Arrows indicate capture beats and asterisks indicate fusion beats.

Fusion and Capture Beats

Слайд 105

Sustained monomorphic ventricular tachycardia with atrioventricular (AV) dissociation. Note the

Sustained monomorphic ventricular tachycardia with atrioventricular (AV) dissociation. Note the independence

of the atrial (sinus) rate (75 per minute) and ventricular (QRS) rate (140 per minute).
Слайд 106

?

?

Слайд 107

Слайд 108

Atrioventricular Conduction Disturbances and Bradyarrhythmias

Atrioventricular Conduction Disturbances and Bradyarrhythmias

Слайд 109

Sites of Disturbances in Impulse Formation or Conduction Leading to

Sites of Disturbances in Impulse Formation
or Conduction Leading to Bradyarrhythmias

SA

Node

AV Node

His-Purkinje
System

Слайд 110

Pacemaker Hierarchy (Dominant vs Subsidiary/Escape Pacemakers) SA Node (+Atria) AV

Pacemaker Hierarchy
(Dominant vs Subsidiary/Escape Pacemakers)

SA
Node
(+Atria)

AV

Junction
(=AVN/His Bundle)

Ventricles
(= Distal Purkinje System)

Intrinsic Rate of Firing

60-100 min−1

40-60 min−1

30-40 min−1

Слайд 111

AV Block

AV Block

Слайд 112

AV Block - Definitions First Degree: Prolonged conduction time Second

AV Block - Definitions

First Degree: Prolonged conduction time
Second Degree: Intermittent non-conduction
Third

Degree: Persistent non-conduction
Слайд 113

First Degree AV Block (PR > .20 sec [1 big

First Degree AV Block
(PR > .20 sec [1 big

box])

II

P

P

P

.36

Site of delay most commonly the AV node,
but may be localized to the His-Purkinje system

Слайд 114

Слайд 115

Second Degree AV Block - Type I (Wenkebach or Mobitz

Second Degree AV Block - Type I
(Wenkebach or Mobitz I

Block)

P

P

P

P

Block

II

Example of 3:2 conduction ratio;
Note PR ↑ prior to block and ↓ post-block
Characteristic of AV nodal site of block

Слайд 116

II Block P P P P P 4:3 conduction ratio

II

Block

P

P

P

P

P

4:3 conduction ratio
Note first RR longer than second RR

Second

Degree AV Block - Type I
(Wenkebach or Mobitz I Block)
Слайд 117

II

II

Слайд 118

II P P P P P P Second Degree AV

II

P

P

P

P

P

P

Second Degree AV Block - Type II
(Mobitz II)

Example of

3:2 conduction ratio;
Note fixed PR for all conducted beats
Characteristic of His-Purkinje system site of block

Block

Block

Слайд 119

Second Degree AV Block - Type II P P P P P 4:3 conduction ratio Block

Second Degree AV Block - Type II

P

P

P

P

P

4:3 conduction ratio

Block

Слайд 120

II P P P P P P 2:1 Second Degree

II

P

P

P

P

P

P

2:1 Second Degree AV Block -
Type I or Type

II?

Is site of block within the AV node or His-Purkinje System?

Слайд 121

EKG/Clinical Clues* to site of 2:1 Second Degree AV block

EKG/Clinical Clues* to site of 2:1 Second Degree AV block

QRS narrow
Improves with

exercise (catecholamine-facilitated conduction)
Observed in setting of increased vagal tone (e.g., sleep) or AV nodal depressant drugs

QRS wide (BBB patterns)
Unchanged (possibly even precipitated) during exercise
May improve with heart rate slowing during increased vagal tone

Favoring AV Node

Favoring His-Purkinje System

Слайд 122

II P P P P P P P P P

II

P

P

P

P

P

P

P

P

P

3:1 conduction ratio, with ventricular rate in the 30’s

Advanced Second Degree

AV Block
(Block of ≥ 2 Consecutive P Waves)
Слайд 123

Site of AV Block vs. Escape Rhythm AV Node: Junctional or ventricular His-Purkinje System: Ventricular

Site of AV Block vs. Escape Rhythm

AV Node: Junctional or ventricular
His-Purkinje

System: Ventricular
Слайд 124

Слайд 125

Third Degree AV Block (Complete Heart Block) P P P

Third Degree AV Block
(Complete Heart Block)

P

P

P

P

P

P

P waves at 60 beats/min

QRS complexes (junctional escape rhythm) at 45 beats/min
Atrial and ventricular activity are completely unrelated
Junctional escape rhythm suggests AV nodal site of block

II

Слайд 126

Unreliability of Ventricular Escape Rhythm in Third Degree AV Block

Unreliability of Ventricular Escape Rhythm
in Third Degree AV Block

P

P

(P)

P

P

P

P

P

P

P

P

P

No QRS

complexes!

P

P

P

(P)

P

15 s

Слайд 127

Слайд 128

Слайд 129

Causes of NON-Physiologic AV Block Ischemic heart disease, cardiomyopathy and

Causes of NON-Physiologic AV Block

Ischemic heart disease, cardiomyopathy and degenerative changes
Drugs

that depress AV conduction
AV Node: digoxin, beta blockers, calcium channel blockers, amiodarone
His-Purkinje System: Antiarrhythmic drugs that depress the inward sodium current
Myocardial infection, infiltration (e.g., tumor)
Trauma (e.g., surgery; therapeutic ablation)
Congenital abnormalities
Слайд 130

Sinus Bradyarrhythmias

Sinus Bradyarrhythmias

Слайд 131

Sinus Bradycardia II P wave upright in leads I and

Sinus Bradycardia

II

P wave upright in leads I and II, just as

in normal sinus rhythm
Слайд 132

Causes of Sinus Bradycardia Increased vagal tone Drugs: beta blockers,

Causes of Sinus Bradycardia

Increased vagal tone
Drugs: beta blockers, calcium channel blockers,

amiodarone, digoxin (indirect effect)
Myocardial ischemia/infarction
Hypothyroidism
“Sick sinus syndrome” - degenerative/fibrotic atrial process
Слайд 133

Sequence of P Wave Generation Sinus Node SA Junction Atrium

Sequence of P Wave Generation

Sinus
Node

SA
Junction

Atrium

(P wave)

Non-visible process on the

EKG
Слайд 134

Inspiration Expiration SA nodal acceleration SA nodal deceleration Sinus Arrhythmia

Inspiration

Expiration

SA nodal acceleration

SA nodal deceleration

Sinus Arrhythmia

Слайд 135

Sinoatrial (SA) Exit Block - Definitions First Degree: Prolonged SA

Sinoatrial (SA) Exit Block - Definitions

First Degree: Prolonged SA conduction time

(non-detectable on EKG; no missing P waves)
Second Degree: Intermittent non-conduction (intermittent absence of P waves)
Third Degree: Persistent non-conduction (complete absence of P waves; escape rhythms only)
Слайд 136

Second Degree SA Exit Block - Type I (Wenkebach) P

Second Degree SA Exit Block - Type I
(Wenkebach)

P

P

P

P

4:3 pattern

Missing
P

wave

PP intervals shorten prior to block
Note unaffected, fixed PR intervals

PP:

Слайд 137

Second Degree SA Exit Block - Type II PP: P

Second Degree SA Exit Block - Type II

PP:

P

P

P

P

P

One P wave abruptly

“drops out” on time

Missing
P wave

Слайд 138

X 2X 2X X P P P P P P

X

2X

2X

X

P

P

P

P

P

P

P

P

2:1 SA Exit Block
(Every Other P wave is “Dropped”)

Atrial rate

is abruptly cut in half

Resolution of block

P

Слайд 139

P P P’ P’ Sinus bradycardia → Sinus arrest →

P

P

P’

P’

Sinus bradycardia → Sinus arrest → Slow junctional escape rhythm

(with retrograde

p waves)

Sinus Arrest

Слайд 140

Tachycardia-Bradycardia (Form of “Sick Sinus”) Syndrome Atrial Flutter Sinus arrest Junctional escape (tardy) Atrial Flutter terminates

Tachycardia-Bradycardia
(Form of “Sick Sinus”) Syndrome

Atrial Flutter

Sinus arrest

Junctional
escape

(tardy)

Atrial Flutter
terminates

Слайд 141

Sinus Arrest → Asystole Sinus rhythm Sinus brady. → Sinus

Sinus Arrest → Asystole

Sinus rhythm

Sinus brady.
→ Sinus arrest
→ V. escape
rhythm

Failure

of V.
escape rhythm
→ Asystole

P

P

P

P

P

P

P

P

Слайд 142

Causes of SA Exit Block and Sinus Pauses/Arrest Increased vagal

Causes of SA Exit Block and Sinus Pauses/Arrest

Increased vagal tone

(very intense for sinus arrest)
Drugs: beta blockers, calcium channel blockers, amiodarone, digoxin (indirect effect)
Myocardial ischemia/infarction
Sick sinus syndrome
Sequela of open heart surgery
Слайд 143

Sick Sinus Syndrome (1) persistent spontaneous sinus bradycardia not caused

Sick Sinus Syndrome

(1) persistent spontaneous sinus bradycardia not caused by drugs

and inappropriate for the physiologic circumstance;
(2) sinus arrest or exit block
(3) combinations of SA and AV conduction disturbances
(4) alternation of paroxysms of rapid regular or irregular atrial tachyarrhythmias and periods of slow atrial and ventricular rates (bradycardia-tachycardia syndrome
Слайд 144

Имя файла: Cardiac-arrhythmias.pptx
Количество просмотров: 62
Количество скачиваний: 0